0

    530163

    KERALAYUR

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    KERALA AYURVEDA LTD. Share Price Today

    Investment Returns

    Over 1 Month -5.98% Over 3 Months -30.38% Over 6 Months -45.60% Over 1 Year -70.64%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    KERALA AYURVEDA LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 215.40
    • P/E Ratio (TTM) -14.62
    • Beta 1.69
    • Book Value / share 28.05
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -7.93
    info icon alternate text

    KERALA AYURVEDA LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 24.57
    Operating Expense 38.26
    Net Profit -7.93
    Net Profit Margin (%) -32.27
    Earnings Per Share (EPS) -6.25
    EBITDA -5.79
    Effective Tax Rate (%) 11.88
    Particulars DEC 2025 (Values in Cr)
    Revenue 22.07
    Operating Expense 26.69
    Net Profit -3.47
    Net Profit Margin (%) -15.72
    Earnings Per Share (EPS) -3.03
    EBITDA -1.08
    Effective Tax Rate (%) 4.93
    Particulars SEP 2025 (Values in Cr)
    Revenue 21.29
    Operating Expense 29.41
    Net Profit -5.40
    Net Profit Margin (%) -25.36
    Earnings Per Share (EPS) -4.58
    EBITDA -2.78
    Effective Tax Rate (%) 8.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 17.57
    Operating Expense 24.99
    Net Profit 2.07
    Net Profit Margin (%) 11.78
    Earnings Per Share (EPS) 1.73
    EBITDA 4.58
    Effective Tax Rate (%) 19.76
    Particulars MAR 2025 (Values in Cr)
    Revenue 19.35
    Operating Expense 34.61
    Net Profit -11.86
    Net Profit Margin (%) -61.29
    Earnings Per Share (EPS) -10.13
    EBITDA -6.61
    Effective Tax Rate (%) -9.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 85.48
    Operating Expense 119.36
    Net Profit -14.74
    Net Profit Margin (%) -17.24
    Earnings Per Share (EPS) -12.21
    EBITDA -5.08
    Effective Tax Rate (%) 7.58
    Particulars MAR 2025 (Values in Cr)
    Revenue 72.69
    Operating Expense 91.35
    Net Profit -13.78
    Net Profit Margin (%) -18.95
    Earnings Per Share (EPS) -11.53
    EBITDA -7.41
    Effective Tax Rate (%) -2.22
    Particulars MAR 2024 (Values in Cr)
    Revenue 68.04
    Operating Expense 71.21
    Net Profit 0.05
    Net Profit Margin (%) 0.07
    Earnings Per Share (EPS) -0.44
    EBITDA 6.80
    Effective Tax Rate (%) 129.41
    Particulars MAR 2023 (Values in Cr)
    Revenue 59.12
    Operating Expense 59.64
    Net Profit 2.89
    Net Profit Margin (%) 4.88
    Earnings Per Share (EPS) 3.09
    EBITDA 7.45
    Effective Tax Rate (%) -21.94
    Particulars MAR 2022 (Values in Cr)
    Revenue 51.72
    Operating Expense 50.79
    Net Profit 0.89
    Net Profit Margin (%) 1.72
    Earnings Per Share (EPS) 1.17
    EBITDA 7.88
    Effective Tax Rate (%) 28.45
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.89
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 5.21
    EBITDA Margin -2.52
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 15.50
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 6.13
    EBITDA Margin 8.17
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 5.28
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 12.18
    EBITDA Margin 3.11
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 5.79
    ROE % 13.28
    ROCE % 9.31
    Total Debt to Total Equity 15.40
    EBITDA Margin 12.30
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3.22
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 12.42
    EBITDA Margin 1.53
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 20.88
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.06
    EBITDA Margin -9.51
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 27.24
    ROE % 0.14
    ROCE % 4.97
    Total Debt to Total Equity 2.69
    EBITDA Margin 9.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 13.77
    ROE % 2.03
    ROCE % 4.85
    Total Debt to Total Equity 4.84
    EBITDA Margin 7.88
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 10.68
    ROE % 5.44
    ROCE % 8.40
    Total Debt to Total Equity 5.97
    EBITDA Margin 14.39
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 9.51
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 5.01
    EBITDA Margin 0.88
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.38
    Total Assets 128.76
    Total Liabilities 128.76
    Total Equity 12.89
    Share Outstanding 1
    Price to Book Ratio 16.82
    Return on Assets (%) -10.84
    Return on Capital (%) -17.7
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 22.80
    Total Assets 133.18
    Total Liabilities 133.18
    Total Equity 21.31
    Share Outstanding 1
    Price to Book Ratio 9.59
    Return on Assets (%) -0.42
    Return on Capital (%) -0.59
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.19
    Total Assets 114.71
    Total Liabilities 114.71
    Total Equity 7.88
    Share Outstanding 1
    Price to Book Ratio 6.06
    Return on Assets (%) -0.78
    Return on Capital (%) -1.12
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.87
    Total Assets 110.31
    Total Liabilities 110.31
    Total Equity 7.94
    Share Outstanding 1
    Price to Book Ratio 7.32
    Return on Assets (%) 2.14
    Return on Capital (%) 3.03
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 18.55
    Total Assets 114.48
    Total Liabilities 114.48
    Total Equity 5.20
    Share Outstanding 1
    Price to Book Ratio 5.40
    Return on Assets (%) -4.23
    Return on Capital (%) -5.91
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.36
    Total Assets 118.88
    Total Liabilities 118.88
    Total Equity 25.12
    Share Outstanding 1
    Price to Book Ratio 16.82
    Return on Assets (%) -11.59
    Return on Capital (%) -17.39
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 16.49
    Total Assets 116.22
    Total Liabilities 116.22
    Total Equity 32.77
    Share Outstanding 1
    Price to Book Ratio 9.59
    Return on Assets (%) 0.04
    Return on Capital (%) 0.06
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.72
    Total Assets 98.70
    Total Liabilities 98.70
    Total Equity 14.53
    Share Outstanding 1
    Price to Book Ratio 6.06
    Return on Assets (%) 2.92
    Return on Capital (%) 3.73
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.13
    Total Assets 91.69
    Total Liabilities 91.69
    Total Equity 11.27
    Share Outstanding 1
    Price to Book Ratio 7.32
    Return on Assets (%) 0.97
    Return on Capital (%) 1.22
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.07
    Total Assets 96.22
    Total Liabilities 96.22
    Total Equity 10.04
    Share Outstanding 1
    Price to Book Ratio 5.40
    Return on Assets (%) -5.14
    Return on Capital (%) -6.51
    Particulars MAR 2025 (Values in Cr)
    Net Income -12.23
    Cash from Operations 6.88
    Cash from Investing -14.76
    Cash from Financing -9.48
    Net change in Cash -19.42
    Free Cash Flow 20.20
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.65
    Cash from Operations 0.08
    Cash from Investing -0.45
    Cash from Financing 19.83
    Net change in Cash 18.41
    Free Cash Flow 1.17
    Particulars MAR 2023 (Values in Cr)
    Net Income 4.26
    Cash from Operations 10.22
    Cash from Investing -7.21
    Cash from Financing -2.31
    Net change in Cash 0.32
    Free Cash Flow 16.41
    Particulars MAR 2022 (Values in Cr)
    Net Income 9.32
    Cash from Operations -0.50
    Cash from Investing -1.90
    Cash from Financing -13.27
    Net change in Cash -15.68
    Free Cash Flow 2.34
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.41
    Cash from Operations 7.42
    Cash from Investing -1.43
    Cash from Financing 6.20
    Net change in Cash 12.19
    Free Cash Flow 8.46
    Particulars MAR 2025 (Values in Cr)
    Net Income -13.48
    Cash from Operations 2.23
    Cash from Investing -6.47
    Cash from Financing -11.93
    Net change in Cash -16.13
    Free Cash Flow 9.04
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.16
    Cash from Operations -4.79
    Cash from Investing -0.53
    Cash from Financing 20.58
    Net change in Cash 14.75
    Free Cash Flow -4.09
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.81
    Cash from Operations 9.11
    Cash from Investing -5.32
    Cash from Financing -2.27
    Net change in Cash 1.52
    Free Cash Flow 10.05
    Particulars MAR 2022 (Values in Cr)
    Net Income 7.12
    Cash from Operations 8.75
    Cash from Investing 0.82
    Cash from Financing -10.51
    Net change in Cash -0.94
    Free Cash Flow 11.05
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.52
    Cash from Operations -0.91
    Cash from Investing -2.10
    Cash from Financing 2.18
    Net change in Cash -0.83
    Free Cash Flow 0.03
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    KERALA AYURVEDA LTD. shareholding pattern

    Holding
    64.19%
    35.6%
    0.16%
    0.03%
    20.35%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    KERALA AYURVEDA LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    165.75 1.59 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 171.20
    • 26 Days 183.00
    • 10 Days 0.00
    • 50 Days 192.40
    • 12 Days 177.00
    • 100 Days 217.40
    • 20 Days 180.60
    • 200 Days 266.10
    163.62 PIVOT
    First Support 157.68 First Resistance 169.08 Second Support 152.22 Second Resistance 175.02 Third Support 146.28 Third Resistance 180.48
    RSI 35.07 ADX 15.60 MACD -5.97 Williams % R -79.57 Commodity Channel Index (CCI) -127.42
    Date 2026-07-10 Week 9057.00 Same Day 3949.00 Month 12852.00
    1 Year 1.69 3 Year 1.03
    Over 1 Month
    -5.98% down
    Over 1 Year
    -70.64% down
    Over 3 Months
    -30.38% down
    Over 3 Years
    16.54% down
    Over 6 Months
    -45.60% down
    Over 5 Years
    22.71% down

    KERALA AYURVEDA LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Kerala Ayurveda Ltd?

    Answer Field

    Kerala Ayurveda Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 165.75 as on Jul 10 2026 03:30 PM.

    What is the Market Cap of Kerala Ayurveda Ltd Share?

    Answer Field

    The market cap of Kerala Ayurveda Ltd for NSE ₹ 0.00 & for BSE ₹ 215.40 as on Jul 10 2026 03:30 PM.

    What is the 52 Week High and Low of Kerala Ayurveda Ltd?

    Answer Field

    The 52 Week High and Low of Kerala Ayurveda Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 610.00 and ₹ 150.00.

    What is 1 year return for Kerala Ayurveda Ltd?

    Answer Field

    The 1 year returns on the stock has been -70.64%.

    What is the P/E Ratio of Kerala Ayurveda Ltd Share?

    Answer Field

    As on Jul 10 2026 03:30 PM the price-to-earnings (PE) ratio for Kerala Ayurveda Ltd share is -14.62.

    What is the PB ratio of Kerala Ayurveda Ltd Share?

    Answer Field

    As on Jul 10 2026 03:30 PM, the price-to-book (PB) ratio for Kerala Ayurveda Ltd share is 28.05.

    How to Buy Kerala Ayurveda Ltd Share?

    Answer Field

    You can trade in Kerala Ayurveda Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Kerala Ayurveda Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Kerala Ayurveda Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Kerala Ayurveda Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |